Synergy CHC, which provides consumer health care, beauty, and lifestyle products, raised $10 million by offering 1.2 million shares at $9, the low end of the range of $9 to $11. The company offered 0.2 million more shares than anticipated.
Synergy CHC had been listed on the OTC Pink (SNYR) but was shifted to the OTC Expert Market on September 28, 2021, which meant that quotes for its common stock were no longer publicly available.
Synergy's current brand portfolio consists of two marquee brands, patented brain health supplement FOCUSfactor and lifestyle brand Flat Tummy, and a developing brand, Hand MD, a range of preventative, restorative, and anti-aging skin care products designed for the hands. Its products are sold through club, mass drug, and other retailers such as Costco, Amazon, Walmart, Walgreens, CVS, The Vitamin Shoppe, Target, H-E-B, and SuperValu.
Synergy CHC plans to list on the Nasdaq under the symbol SNYR. Roth Capital acted as sole bookrunner on the deal.
